Our study demonstrates that the prognostic impact of TIL-Bs in OCSCCs is independent of the total number of tumor-infiltrating lymphocytes, as displayed by the more favorable five-year OS and DFS of OCSCCs with a high CD19/CD45 ratio compared to oral cancers with a low CD19/CD45 ratio. Here, CD19 is linked to neoplasm.